Roivant Sciences (ROIV) Cash & Current Investments (2021 - 2026)
Roivant Sciences (ROIV) reported Cash & Current Investments of $3.84 billion for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 14.7% from $4.5 billion a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences posted Cash & Current Investments of $4.29 billion, down 12.2% from FY2025.
- Cash & Current Investments has a five-year compound annual growth rate of 15.9% (FY2021 to FY2026).
- By fiscal year, Cash & Current Investments came in at $4.89 billion in FY2025 (-24.8%), $6.49 billion in FY2024 (+287.3%), $1.68 billion in FY2023 (-18.6%) and $2.06 billion in FY2022 (+0.3%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Cash & Current Investments since fiscal Q2 2024.
- Year over year, Cash & Current Investments has now declined in each of the last seven quarters, with growth averaging 19.5% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was fiscal Q3 2024 (growth of 338.6%); the low point was fiscal Q2 2023 (a decline of 36.0%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $4.29 billion (Q4 2026), $4.53 billion (Q3 2026) and $4.39 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Roivant Sciences | 26.42 Bn | 9.37 Bn | 1.16 Mn | 3.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.84 Bn |
| Mar 31, 2026 | 4.29 Bn |
| Dec 31, 2025 | 4.53 Bn |
| Sep 30, 2025 | 4.39 Bn |
| Jun 30, 2025 | 4.50 Bn |
| Mar 31, 2025 | 4.89 Bn |
| Dec 31, 2024 | 5.15 Bn |
| Sep 30, 2024 | 5.39 Bn |
| Jun 30, 2024 | 5.70 Bn |
| Mar 31, 2024 | 6.49 Bn |
| Dec 31, 2023 | 6.70 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.43 Bn |
| Mar 31, 2023 | 1.68 Bn |
| Dec 31, 2022 | 1.53 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.94 Bn |
| Mar 31, 2022 | 2.06 Bn |
| Dec 31, 2021 | 2.21 Bn |
| Sep 30, 2021 | 2.50 Bn |
API Access
Roivant Sciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();